Deciphera Pharmaceuticals, Inc. insider trading activity
Understanding Insider Activity at Deciphera Pharmaceuticals, Inc.
Welcome to our dedicated page for Deciphera Pharmaceuticals, Inc. (Nasdaq: DCPH) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Deciphera Pharmaceuticals, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Deciphera Pharmaceuticals, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for DCPH| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| DCPH | 9:06:00 PM 2/20/2024 | Sherman Matthew L(EVP & Chief Medical Officer) sold 2615 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$40846 | Filing |
| DCPH | 9:05:46 PM 2/20/2024 | Kelly Thomas Patrick(Chief Financial Officer) sold 3010 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$47016 | Filing |
| DCPH | 9:05:37 PM 2/20/2024 | Pitman Jama(SVP, Chief Development Officer) sold 2267 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$35410 | Filing |
| DCPH | 9:05:14 PM 2/20/2024 | Martin Daniel C.(Chief Commercial Officer) sold 2267 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$35410 | Filing |
| DCPH | 9:15:48 PM 1/18/2024 | Sherman Matthew L(EVP & Chief Medical Officer) sold 2435 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$35234 | Filing |
| DCPH | 9:15:39 PM 1/18/2024 | Pitman Jama(SVP, Chief Development Officer) sold 1624 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$23499 | Filing |
| DCPH | 9:15:29 PM 1/18/2024 | Kelly Thomas Patrick(Chief Financial Officer) sold 2435 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$35234 | Filing |
| DCPH | 9:15:19 PM 1/18/2024 | Martin Daniel C.(Chief Commercial Officer) sold 1624 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$23499 | Filing |
| DCPH | 9:05:15 PM 12/14/2023 | Hoerter Steven L.(President and CEO) sold 30664 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$471305 | Filing |
| DCPH | 9:05:14 PM 12/14/2023 | Kelly Thomas Patrick(Chief Financial Officer) sold 2792 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$42913 | Filing |
| DCPH | 9:05:13 PM 12/14/2023 | Pitman Jama(See Remarks) sold 1662 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$25544 | Filing |
| DCPH | 9:05:10 PM 12/14/2023 | Martin Daniel C.(Chief Commercial Officer) sold 1727 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$26543 | Filing |
| DCPH | 9:05:07 PM 12/14/2023 | Sherman Matthew L(EVP & Chief Medical Officer) sold 2792 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$42913 | Filing |
| DCPH | 9:05:12 PM 12/1/2023 | Martin Daniel C.(Chief Commercial Officer) sold 17801 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$223758 | Filing |
| DCPH | 8:11:28 PM 10/31/2023 | Sherman Matthew L(EVP & Chief Medical Officer) sold 2360 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$28367 | Filing |
| DCPH | 8:10:50 PM 10/31/2023 | Pitman Jama(See Remarks) sold 1407 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$16912 | Filing |
| DCPH | 8:10:24 PM 10/31/2023 | Martin Daniel C.(Chief Commercial Officer) sold 1407 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$16912 | Filing |
| DCPH | 8:09:39 PM 10/31/2023 | Kelly Thomas Patrick(Chief Financial Officer) sold 2316 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$27838 | Filing |
| DCPH | 8:09:14 PM 10/31/2023 | Hoerter Steven L.(President and CEO) sold 21573 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$259307 | Filing |
| DCPH | 8:05:11 PM 10/4/2023 | Sherman Matthew L(EVP & Chief Medical Officer) sold 2942 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$37304 | Filing |
| DCPH | 8:05:35 PM 6/21/2023 | Pitman Jama(See Remarks) sold 1238 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$17827 | Filing |
| DCPH | 8:05:30 PM 6/21/2023 | Sherman Matthew L(EVP & Chief Medical Officer) sold 1655 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$23832 | Filing |
| DCPH | 8:05:23 PM 6/21/2023 | Kelly Thomas Patrick(Chief Financial Officer) sold 1655 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$23832 | Filing |
| DCPH | 8:05:17 PM 6/21/2023 | Martin Daniel C.(Chief Commercial Officer) sold 1238 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$17827 | Filing |
| DCPH | 8:05:15 PM 6/21/2023 | Flynn Daniel Lee(Chief Scientific Officer) sold 1655 shares of Deciphera Pharmaceuticals, Inc. (DCPH) for ~$23832 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 41 insider filings.
Register now to dive deeper and explore the full dataset.
Discover more companies
- DCP Midstream, LP (DCP-PC)
- DCP Midstream, LP (DCP-PB)
- DCP Midstream, LP (DCP)
- Dime Community Bancshares, Inc. /NY/ (DCOMP)
- Decarbonization Plus Acquisition Corp IV (DCRD)
- Decarbonization Plus Acquisition Corp IV (DCRDU)
- Decarbonization Plus Acquisition Corp IV (DCRDW)
- Decarbonization Plus Acquisition Corp V (DCRE)